Charlotte's Web Q1 2026 revenue down 9% to $11.2M, net loss $13.1M, proposes BAT transaction to eliminate debenture

Charlotte's Web Holdings, Inc.

2026-Q1 EPS reported -$0.08 revenue$11,159,000

Revenue $11.2M vs $12.3M in Q1 2025; net loss includes $8.9M non-cash fair value charge on BAT convertible debenture.
Proposed transaction with BAT to convert ~$54M debenture and invest $10M, eliminating $3M annual interest; shareholder vote May 28, 2026.
CMS BEI program activated April 1, 2026, allowing hemp-derived CBD coverage up to $500/beneficiary; FDA issued limited enforcement discretion.
Adjusted EBITDA improved to -$1.7M from -$2.8M; SG&A down 17.7% to $9.5M; OTCQX upgrade completed post-quarter.
DeFloria Phase 2 trial for ASD irritability candidate AJA001 expected mid-2026; in-house gummy manufacturing substantially complete.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Charlotte's Web Holdings, Inc. reported financial results for the quarter ended March 31, 2026.

Period: the quarter ended March 31, 2026
Result: reported results

Exact text from the filing

On May 13, 2026, Charlotte’s Web Holdings, Inc. (the “Company”) issued an earnings release announcing its financial results for the three months ended March 31, 2026.

View on SEC.gov

571 earnings releases filed in the last 30 days. Browse all earnings releases →

Charlotte's Web Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001750155-26-000076

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.